Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Rheumatology (Oxford). 2010 Feb;49(2):326-33. doi: 10.1093/rheumatology/kep369. Epub 2009 Dec 1.
To investigate the validity and responsiveness of the World Health Organization Disability Schedule II (WHODAS II) in patients with established RA.
In 85 RA patients admitted for rehabilitation, the WHODAS II (0-100) was applied at admission and 6 weeks after discharge. Additional assessments included measures of physical and psychological functioning, disease activity and quality of life. The internal consistency of the WHODAS II was determined with Cronbach's-alpha. Associations between the WHODAS II and other outcome measures were determined by Pearson's rank correlation coefficients. Responsiveness measures included the standardized response mean (SRM), effect size (ES) and responsiveness ratio (RR).
Cronbach's-alpha of the WHODAS II total score was 0.91. The baseline WHODAS II total score correlated significantly with all other outcome measures, except for the 50-feet walk test, the timed-stands test and the Escola Paulista de Medicina Range of Motion scale. The mean WHODAS II total score improved from 40.5 (s.d. 14.9) at baseline to 4.6 at 6 weeks after discharge (95% CI -8.1, -1.2). The WHODAS II responsiveness scores were -0.35 (SRM), -0.34 (ES) and -0.58 (RR) at 6 weeks after discharge. CONCLUSION; The WHODAS II appeared to be internally consistent, valid and responsive to assess disability in patients with established RA admitted for multidisciplinary team care in terms of International Classification of Functioning, Disability and Health. The WHODAS II showed significant floor effects regarding the subscales--'understanding communicating' and 'getting along with people'. In a multidisciplinary setting, the additional use of measures to evaluate personal and environmental factors seems warranted.
调查世界卫生组织残疾评定量表 II(WHODAS II)在确诊 RA 患者中的有效性和反应度。
在 85 名接受康复治疗的 RA 患者中,在入院时和出院后 6 周时应用 WHODAS II(0-100)进行评估。其他评估包括身体和心理功能、疾病活动度和生活质量的测量。采用 Cronbach's-alpha 评估 WHODAS II 的内部一致性。通过 Pearson 秩相关系数确定 WHODAS II 与其他结局测量的相关性。反应度测量指标包括标准化反应均数(SRM)、效应量(ES)和反应比(RR)。
WHODAS II 总分的 Cronbach's-alpha 值为 0.91。基线 WHODAS II 总分与除 50 英尺步行测试、定时站立测试和 Escola Paulista de Medicina 活动范围量表外的所有其他结局测量均显著相关。WHODAS II 总分从基线时的 40.5(标准差 14.9)改善至出院后 6 周时的 4.6(95%CI -8.1,-1.2)。出院后 6 周时,WHODAS II 的反应度评分分别为 -0.35(SRM)、-0.34(ES)和-0.58(RR)。
WHODAS II 表现出较好的内部一致性、有效性和反应度,可用于评估接受多学科团队治疗的确诊 RA 患者的残疾程度,符合国际功能、残疾和健康分类。WHODAS II 在“理解和交流”及“与人相处”两个分量表上具有显著的地板效应。在多学科环境中,似乎需要额外使用评估个人和环境因素的测量。